UMEM Research Studies

COVID Home SpO2

Sponsor: N/A | Status: Recruiting

Start Date: 05/18/2020 | End Date: -

Principal Investigator(s)
Gentry Wilkerson

Secondary Investigator(s)
Angela Smedley
Christy Carter

Description:

Title: Home Pulse Oximetry Monitoring for Patients Under Investigation for SARS-CoV-2 Infection: An Evaluation of Patient Engagement and Reported Symptoms 

Primary Investigator: R. Gentry Wilkerson, MD, FACEP, FAAEM

Research Team: 

- Youssef Annous MD (yannous@som.umaryland.edu)

- Eli Farhy MS3 (Eli.Farhy@som.umaryland.edu)

- Jonathan Hurst MS3 (Jonathan.Hurst@som.umaryland.edu)

Study Design:

A prospective, non blinded, nonrandomized trial will be conducted at the University of Maryland Medical Center Downtown Campus (UMMC) located in Baltimore, Maryland. The study population will consist of a convenience sample of patients seen in the Emergency Department at hospital for symptoms consistent with possible SARS-CoV-2 infection but determined to be well enough to be discharged home by the clinical care team. This exploratory study aims to evaluate patient engagement in a program to monitor home pulse oximetry and development of symptoms for patients with or under investigation for infection with SARS-CoV-2. Engagement will be measured by determining the rate of loss to follow up and patient compliance rates with recording SpO2 levels and the presence of symptoms.

Objectives: To evaluate patient engagement in a program to monitor home pulse oximetry and development of symptoms for patients with or under investigation for infection with SARS-CoV-2. Engagement will be measured by determining the rate of loss to follow up and patient compliance rates with recording SpO2 levels and the presence of symptoms. 

Primary Endpoint(s): 

- Determination of the proportion of subjects that remain engaged in the program through the end of the 14-day study period. 

- Determination of the median number of days out of 14 that the subjects have data values recorded by study team members.

Keywords: SARS-CoV-2, COVID-19, Pulse Oximetry, Pulse Oximeter